Clinical impact of Neoral in thoracic organ transplantation.
Department of Transplantation Surgery, Wythenshawe Hospital, Manchester, United Kingdom.
T
T
Aziz
A
A
el-Gamel
B
B
Keevil
P
P
Krysiak
C
C
Campbell
A
A
Rahman
A
A
Deiraniya
N
N
Yonan
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D016041:Heart-Lung Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007677:Kidney Function Tests; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013997:Time Factors
D007166:Immunosuppressive Agents; D016572:Cyclosporine